SELLAS Life Sciences Group, Inc. (SLS)
14.32
-1.14
(-7.34%)
USD |
NASDAQ |
Aug 24, 16:00
14.32
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Debt to Equity Ratio : 0.0054 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0054 |
| March 31, 2026 | 0.0081 |
| December 31, 2025 | 0.0141 |
| September 30, 2025 | 0.0131 |
| June 30, 2025 | 0.0282 |
| March 31, 2025 | 0.0313 |
| December 31, 2024 | 0.1058 |
| September 30, 2024 | 0.0362 |
| June 30, 2024 | 0.2376 |
| March 31, 2024 | 0.0827 |
| December 31, 2023 | -0.1136 |
| September 30, 2023 | -0.1683 |
| June 30, 2023 | 0.1547 |
| March 31, 2023 | 0.0645 |
| December 31, 2022 | 0.1948 |
| September 30, 2022 | 0.0822 |
| June 30, 2022 | 0.059 |
| March 31, 2022 | 0.3001 |
| December 31, 2021 | 0.0397 |
| September 30, 2021 | 0.0322 |
| June 30, 2021 | 0.027 |
| March 31, 2021 | 0.033 |
| December 31, 2020 | 0.0354 |
| September 30, 2020 | 0.127 |
| June 30, 2020 | 0.2665 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0153 |
| December 31, 2019 | 0.0356 |
| September 30, 2019 | 0.0288 |
| June 30, 2019 | 0.0272 |
| March 31, 2019 | 0.1597 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0041 |
| June 30, 2018 | -3.133 |
| March 31, 2018 | -7.341 |
| December 31, 2017 | 5.308 |
| September 30, 2017 | 0.8315 |
| June 30, 2017 | 0.681 |
| March 31, 2017 | 0.4632 |
| December 31, 2016 | 0.5722 |
| September 30, 2016 | 0.9913 |
| June 30, 2016 | 1.140 |
| March 31, 2016 | 0.3013 |
| December 31, 2015 | 0.3507 |
| September 30, 2015 | 0.1756 |
| June 30, 2015 | 0.1342 |
| March 31, 2015 | 0.1274 |
| December 31, 2014 | 0.2267 |
| September 30, 2014 | 0.3008 |
| June 30, 2014 | 0.3569 |
| March 31, 2014 | 0.2153 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Savara, Inc. | 0.2117 |
| Lite Strategy, Inc. | 0.00 |
| AbbVie, Inc. | -11.93 |
| Marker Therapeutics, Inc. | 0.00 |
| Rezolute, Inc. | 0.0095 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 145.38M |
| Total Liabilities (Quarterly) | 7.726M |
| Shareholders Equity (Quarterly) | 137.66M |
| Current Ratio | 18.83 |
| Net Debt Paydown Yield | 0.00% |